https://www.selleckchem.com/products/dmb.html
To evaluate the prevalence and risk factors of new-onset glucose metabolism impairment using an oral glucose tolerance test (OGTT) in patients with normal fasting glycaemia on long-term glucocorticoid (GC) treatment. An OGTT was performed in 150 patients without a previous history of pre-diabetes or diabetes who were diagnosed with inflammatory rheumatic diseases and treated with GCs 3 months. All participants underwent clinical and biochemical evaluation for risk factors of diabetes age, ****, current and cumulative dose of steroids, tr
Respect!
Kommentar
Delen
